View the programme for Immuno-Oncology 2015 online or download a PDF file of the latest version.
- Checkpoint inhibition
- Cancer neo-antigens
- Immunomodulatory antibodies
- PD-1/PD-L1 axis blockade, results to date
- Immuno-oncology meets molecular oncology
- Adoptive T cell therapy
- Immuno-Oncology clinical studies across tumour types (breast, lung, brain, gastrointestinal, genitourinary, gynaecology, melanoma, lymphoma)
ESMO-MORA: The Symposium programme has been accredited with 12 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possesses the necessary skills and standards for the practice of medical oncology. See here for further details.
CME: The programme will also be submitted for accreditation to the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found online here.
The Symposium webcasts will include all the sessions of the official programme, where speaker permission is granted, and will be available on this website and OncologyPRO for ESMO members.